About: Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome
Creator	Kong, Jian Kou, Yu Li, Xie Mayol, Julio Neumayer, Christoph Alfageme-Lopez, Nuria Kampusch, Stefan Kaniusas, Eugenijus Panetsos, Fivos Papa, Michele Szeles, Jozsef Yucuma-Conde, Daniela Lai, Ching
source	Medline; PMC
abstract	Background: Covid-19 is an infectious disease caused by an invasion of the alveolar epithelial cells by coronavirus 19. The most severe outcome of the disease is the Acute Respiratory Distress Syndrome (ARDS) combined with hypoxemia and cardiovascular damage. ARDS and co-morbidities are associated with inflammatory cytokine storms, sympathetic hyperactivity, and respiratory dysfunction. Hypothesis: In the present paper, we present and justify a novel potential treatment for Covid19-originated ARDS and associated co-morbidities, based on the non-invasive stimulation of the auricular branch of the vagus nerve. Methods: Auricular vagus nerve stimulation activates the parasympathetic system including anti-inflammatory pathways (the cholinergic anti-inflammatory pathway and the hypothalamic pituitary adrenal axis) while regulating the abnormal sympatho-vagal balance and improving respiratory control. Results: Along the paper (1) we expose the role of the parasympathetic system and the vagus nerve in the control of inflammatory processes (2) we formulate our physiological and methodological hypotheses (3) we provide a large body of clinical and preclinical data that support the favorable effects of auricular vagus nerve stimulation in inflammation, sympatho-vagal balance as well as in respiratory and cardiac ailments, and (4) we list the (few) possible collateral effects of the treatment. Finally, we discuss auricular vagus nerve stimulation protective potential, especially in the elderly and co-morbid population with already reduced parasympathetic response. Conclusions: Auricular vagus nerve stimulation is a safe clinical procedure and it could be either an effective treatment for ARDS originated by Covid-19 and similar viruses or a supplementary treatment to actual ARDS therapeutic approaches.
has issue date	2020-07-28(xsd:dateTime)
bibo:doi	10.3389/fphys.2020.00890
bibo:pmid	32848845
has license	cc-by
sha1sum (hex)	aea4430c54b58d33074eef6f85da871d0e960c34
schema:url	https://doi.org/10.3389/fphys.2020.00890
resource representing a document's title	Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome
has PubMed Central identifier	PMC7399203
has PubMed identifier	32848845
schema:publication	Front Physiol
resource representing a document's body	covid:aea4430c54b58d33074eef6f85da871d0e960c34#body_text
is schema:about of	named entity 'coronavirus' named entity 'infectious disease' named entity 'Nerve' named entity 'RESPIRATORY DYSFUNCTION' named entity 'hypoxemia' named entity 'dysfunction' named entity 'hyperactivity' named entity 'alveolar epithelial cells' named entity 'hyperactivity' named entity 'cardiovascular' named entity 'Non-invasive' named entity 'Auricular' named entity 'Acute Respiratory Distress Syndrome' named entity 'RNA' named entity 'therapeutic effects' named entity 'Akella' named entity 'IL-1' named entity 'acute lung injury' named entity 'vagus nerve' named entity 'cardiogenic shock' named entity 'cardiovascular' named entity 'peripheral arteries' named entity 'vasculitis' named entity 'T-cells' named entity 'TRIF' named entity 'HPAA' named entity 'PAMP' named entity 'pneumonia' named entity 'ARDS' named entity 'cytokines' named entity 'vagal' named entity 'VNS' named entity 'ACTH' named entity 'ARDS' named entity 'co-morbidities' named entity 'viral RNA' named entity 'mice' named entity 'lacrimation' named entity 'efferents' named entity 'clinical treatment' named entity 'GCSF' named entity 'hypertension' named entity 'Covid' named entity 'ulcerative colitis' named entity 'inflammation' named entity 'ARDS' named entity 'Kawasaki disease' named entity 'attenuation' named entity 'parasympathetic tone' named entity 'epinephrine' named entity 'lung function' named entity 'VNS' named entity 'vacuolation' named entity 'cytokines' named entity 'adrenal glands' named entity 'sepsis' named entity 'sympatho' named entity 'IL-17' named entity 'inflammation' named entity 'zona fasciculata' named entity 'vagal' named entity 'lung injury' named entity 'Lehtimäki' named entity 'outer ear' named entity 'autonomic nervous' named entity 'gastric content' named entity 'glucocorticoids' named entity 'ARDS' named entity 'norepinephrine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software